Deborah H. Telman - Mar 10, 2023 Form 4 Insider Report for GILEAD SCIENCES, INC. (GILD)

Role
EVP, Corporate Affairs & GC
Signature
/s/ Amy Kim by Power of Attorney for Deborah H. Telman
Stock symbol
GILD
Transactions as of
Mar 10, 2023
Transactions value $
$0
Form type
4
Date filed
3/13/2023, 08:50 PM
Previous filing
Feb 23, 2023
Next filing
May 26, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction GILD Restricted Stock Unit Award +10.2K +31.04% 43.1K Mar 10, 2023 Common Stock 10.2K Direct F1, F2
transaction GILD Non-qualified Stock Option (Right to Buy) Award $0 +46.6K $0.00 46.6K Mar 10, 2023 Common Stock 46.6K $79.50 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock.
F2 The restricted stock units have a four-year vesting schedule. 25% vest on the first anniversary of the date of the grant. The balance will vest 6.25% quarterly thereafter until fully vested.
F3 The shares subject to the option have a four-year vesting schedule. 25% vest on the first anniversary of the date of the grant. The balance will vest 6.25% quarterly thereafter until fully vested.